Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Pharmacotherapy|May 16, 2002
Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteersStephen C Piscitelli, Elizabeth Formentini, Aaron H Burstein, et al.
Critical Care Medicine|May 29, 2003
Cytochrome P450 3A4 activity after surgical stressCurtis E Haas, David C Kaufman, Carolyn E Jones, et al.
Journal of Clinical Pharmacology|November 15, 2006
Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokersHélène M Faessel, Megan A Gibbs, David J Clark, et al.
Clinical Pharmacokinetics|November 9, 2010
A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessationHélène M Faessel, R Scott Obach, Hans Rollema, et al.
BMC Neurology|January 16, 2014
Effect of TTP488 in patients with mild to moderate Alzheimer's diseaseAaron H Burstein, Imogene Grimes, Douglas R Galasko, et al.
The Journal of Physiology|April 17, 2002
Modulation of human corticomotor excitability by somatosensory inputAlain Kaelin-Lang, Andreas R Luft, Lumy Sawaki, et al.
Journal of Clinical Pharmacology|August 22, 2006
Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokersHélène M Faessel, Bill J Smith, Megan A Gibbs, et al.
The Journal of Prevention of Alzheimer'S Disease|October 27, 2025
The impact of recent approvals on future alzheimer's disease clinical development: Statistical considerations for combination trialsSamuel P Dickson, Craig Mallinckrodt, Aaron H Burstein, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
Plasma pharmacokinetics of sulfadiazine administered twice daily versus four times daily are similar in human immunodeficiency virus-infected patientsM Kelli Jordan, Aaron H Burstein, Diane Rock-Kress, et al.
Pageof 3